Communiqués Immutep Limited

Actions

IMM

AU000000IMM6

Recherche biotechnologique et médicale

Temps Différé Australian S.E. 02:57:02 27/08/2026			Varia. 5j.	Varia. 1 janv.
0,0520 ^AUD	0,00 %		+1,96 %	-87,47 %

14/07	Immutep obtient un nouveau brevet aux États-Unis pour ses méthodes de traitement du cancer	MT
14/07	Immutep obtient un nouveau brevet américain pour une méthode de traitement du cancer ; l'action recule de 4 %	MT

Communiqués

30/07	Immutep Quarterly Activities Report Q4 FY26	AQ
27/07	Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology Congress 2026	AQ
24/07	Immutep : Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026	PU
14/07	Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor	AQ
13/07	Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004	PU
30/06	Robbins LLP Urges IMMP Stockholders to Move for Lead Plaintiff Before the July 6, 2026 Deadline	NE
06/06	IMMP SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
04/06	Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026	AQ
02/06	IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
01/06	SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
31/05	IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
30/05	IMMP CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
29/05	IMMP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
28/05	Immutep : Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients	PU
27/05	IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
26/05	Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights	BU
25/05	IMMP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
23/05	IMMP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
21/05	IMMP EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
20/05	IMMP SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
19/05	IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
15/05	IMMP CLASS ACTION ALERT: Johnson Fistel Encourages Immutep Limited Shareholders to Submit Their Information Before July 6, 2026 Lead Plaintiff Deadline	NE
13/05	IMMP CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
12/05	IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE
09/05	IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026	NE